Advertisement
Screener

Tandem Diabetes Care, Inc. (TNDM) Material Contracts

Tandem Diabetes Care, Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-05-21: Form 8-K; Exhibit 10.1; Description Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended..
  • 2026-02-27: Form 8-K; Exhibit 10.1; Description Form of Confirmation for Capped Call Transactions.
  • 2025-08-06: Form 10-Q; Exhibit 10.2; Description First Amendment to Settlement, Mutual Release and Cross-License Agreement, dated May 28, 2025, by and between Tandem Diabetes Care, Inc. and F. Hoffmann-La Roche AG.
  • 2025-08-06: Form 10-Q; Exhibit 10.1; Description Settlement, Mutual Release and Cross-License Agreement, dated May 21, 2025, by and between Tandem Diabetes Care, Inc. and F. Hoffmann-La Roche AG.
FiledFormExhibitDescription
2026-05-218-K10.1Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended.
2026-02-278-K10.1Form of Confirmation for Capped Call Transactions
2025-08-0610-Q10.2First Amendment to Settlement, Mutual Release and Cross-License Agreement, dated May 28, 2025, by and between Tandem Diabetes Care, Inc. and F. Hoffmann-La Roche AG
2025-08-0610-Q10.1Settlement, Mutual Release and Cross-License Agreement, dated May 21, 2025, by and between Tandem Diabetes Care, Inc. and F. Hoffmann-La Roche AG
2025-04-3010-Q10.1Non-Employee Director Compensation Policy
2025-02-2610-K10.29EX-10.29 NON-EMPLOYEE DIRECTOR COMPENSATION
2025-02-2610-K10.28EX-10.28 AMENDMENT NO 2 TO DISTRIBUTOR AGREEMENT
2025-02-2610-K10.26EX-10.26 EMPLOYMENT SEVERANCE AGREEMENT
2024-08-0110-Q10.5Amendment No. 1 to Distributor Agreement, dated May 10, 2024, by Unomedical a/s and the Company.
2024-08-0110-Q10.4Employment Severance Agreement, dated June 21, 2024, by and between Tandem Diabetes Care, Inc. and Jean-Claude Kyrillos.
2024-08-0110-Q10.3Employee Offer Letter, dated June 10, 2024, by and between Tandem Diabetes Care, Inc. and Jean-Claude Kyrillos.
2024-08-0110-Q10.2Amended and Restated Commercialization Agreement, dated May 22, 2024, by and between the Company and DexCom, Inc.
2024-08-0110-Q10.1Amended and Restated Development Agreement, dated May 22, 2024, by and between the Company and DexCom, Inc.
2024-03-118-K10.1Form of Confirmation for Capped Call Transactions
2024-02-2110-K10.25EX-10.25 EMPLOYEE OFFER LETTER
2023-12-118-K10.1EX-10.1 SEPARATION AGREEMENT
2023-08-188-K10.1Separation Agreement, executed as of August 18, 2023, entered into by and between Tandem Diabetes Care, Inc. and Brian Hansen.
2023-08-0310-Q10.2Form of Restricted Stock Units Agreement under the 2023 Long-Term Incentive Plan.
2023-08-0310-Q10.1Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan
2023-05-0310-Q10.1Tandem Diabetes Care, Inc. 2023 Senior Management Cash Bonus Plan
2023-02-2210-K10.33EX-10.33 AGREEMENT
2022-08-0310-Q10.2Confidential Intellectual Property Agreement, dated July 10, 2012, by and between Tandem Diabetes Care, Inc. and Smiths Medical ASD, Inc.
2022-08-0310-Q10.1Credit Agreement Between Tandem Diabetes Care, Inc., and Bank of America, N.A.
2022-05-0410-Q10.1Tandem Diabetes Care, Inc. 2022 Senior Management Cash Bonus Plan
2022-02-2210-K10.36EX-10.36 AGREEMENT
2022-02-2210-K10.35EX-10.35 AGREEMENT
2021-11-0310-Q10.1LEASE AGREEMENT
2021-05-0510-Q10.2Tandem Diabetes Care, Inc. 2021 Senior Management Cash Bonus Plan
2021-05-0510-Q10.1Second Amendment to Lease Agreement, dated March 11, 2021, by and between TREA Pacific Plaza, LLC and Tandem Diabetes Care, Inc.
2021-02-2410-K10.25Commercialization Agreement, dated November 20, 2020, by and between Tandem Diabetes Care, Inc. and DexCom, Inc.
2021-02-2410-K10.24Development Agreement, dated November 20, 2020, by and between Tandem Diabetes Care, Inc. and DexCom, Inc.
2020-11-0510-Q10.2Fifth Amendment to Lease Agreement by and Between ARE-11025/11075 ROSELLE STREET, LLC, and Tandem Diabetes Care, Inc.
2020-11-0510-Q10.1Second Amendment to Lease Agreement by and Between ARE-11025/11075 ROSELLE STREET, LLC, and Tandem Diabetes Care, Inc.
2020-07-3010-Q10.2EXHIBIT 10.2 AMENDED 2013 STOCK PLAN
2020-07-3010-Q10.1EXHIBIT 10.1 FORM OF AGREEMENT RSU
2020-04-3010-Q10.2EXHIBIT 10.2 BONUS PLAN
2020-04-3010-Q10.1EXHIBIT 10.1 AGREEMENT
2020-02-2410-K10.36EXHIBIT 10.36 LEASE AGREEMENT
2019-08-0110-Q10.1First Amendment to Lease Agreement, dated May 17, 2019, by and between Tandem Diabetes Care, Inc. and TREA PACIFIC PLAZA, LLC
2019-04-3010-Q10.4EX-10.4 AMENDED AND RESTATED SEVERANCE AGREEMENT WITH JOHN F. SHERIDAN
2019-04-3010-Q10.3EX-10.3 BONUS PLAN
2019-04-3010-Q10.2EX-10.2 LEASE AGREEMENT BY AND BETWEEN TANDEM AND R.E. HAZARD
2019-04-3010-Q10.1EX-10.1 LEASE AGREEMENT BY AND BETWEEN TREA PACIFIC PLAZA, LLC AND TANDEM DIABETES CARE, INC.
2018-11-0910-Q/A10.5Development Agreement, dated June 4, 2015 by and between Tandem Diabetes Care, Inc. and Dexcom, Inc.
2018-11-0110-Q10.5EX-10.5 AGREEMENT BY AND BETWEEN TANDEM DIABETES CARE, INC AND DEXCOM, INC.
2018-08-038-K10.1EX-10.1 UNDERWRITING AGREEMENT
2018-07-3010-Q10.4EX-10.4 CASH BONUS PLAN FOR EXEC
2018-07-3010-Q10.3EX-10.3 BLICKENSTAFF LETTER AGREEMENT
2018-02-078-K10.1EX-10.1 WAIVER AND AMENDMENT NO. 5
2018-01-038-K10.2EX-10.2 FOURTH AMENDMENT TO LEASE, DATED DECEMBER 27, 2017, BY AND BETWEEN TANDEM DIABETES CARE, INC. AND ARE-11025/11075 ROSELLE STREET, LLC
2018-01-038-K10.1EX-10.1 FIRST AMENDMENT TO LEASE, DATED DECEMBER 27, 2017, BY AND BETWEEN TANDEM DIABETES CARE, INC. AND ARE-11025/11075 ROSELLE STREET, LLC
2017-10-2610-Q10.1EX-10.1 DEVELOPMENT AGREEMENT
2016-07-2810-Q10.3EX-10.3 BARNES CANYON LEASE AGREEMENT
2016-02-2410-K10.14TANDEM DIABETES CARE, INC. 2016 CASH BONUS PLAN.
2016-02-2410-K10.5AMENDMENT NO. 3 TO TERM LOAN AGREEMENT
2016-02-028-K10.2Employment Severance Agreement, dated February 1, 2016, by and between Tandem Diabetes Care, Inc. and Brian B. Hansen.
2016-02-028-K10.1Employee Offer Letter, dated January 12, 2016, by and between Tandem Diabetes Care, Inc. and Brian B. Hansen.
2015-11-258-K10.1Retirement Agreement, executed as of November 23, 2015, entered into by and between Tandem Diabetes Care, Inc. and Robert B. Anacone.
2015-10-2910-Q10.2AMENDMENT NO. 1 TO
2015-10-2910-Q10.1AMENDED & RESTATED DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
2015-04-3010-Q10.1Omnibus Amendment No. 2, dated February 23, 2015, by and between Tandem Diabetes Care, Inc., Capital Royalty Partners II L.P., Capital Royalty Partners II-Parallel Fund “A” L.P, Capital Royalty Partners II (Cayman) L.P., Capital Royalty Partners II - Parallel Fund “B” (Cayman) L.P. and Parallel Investment Opportunities Partners II L.P.
2015-02-2410-K10.252015 Cash Bonus Plan
2014-07-3110-Q10.3Consent and Amendment Agreement to the Amended and Restated Term Loan Agreement and Term Loan Agreement, dated as of June 20, 2014.
2014-06-208-K10.1Tandem Diabetes Care, Inc. Nonqualified Deferred Compensation Plan and Form of Adoption Agreement
2014-05-0610-Q10.2TERM LOAN AGREEMENT
2014-05-0610-Q10.1AMENDED AND RESTATED TERM LOAN AGREEMENT
2014-03-0610-K10.222014 Cash Bonus Plan

Similar stocks

Stock NameCountryMarket CapPE Ratio
IRADIMED CORP (IRMD)United States$1.089B52.92
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
ARTIVION, INC. (AORT)United States$1.123B-345.09
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
SpyGlass Pharma, Inc. (SGP)United States$0.925B
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B